SKBSY vs. PFE
SKBSY (Skanska AB ser. B ADR) and PFE (Pfizer Inc.) are both stocks. SKBSY operates in Engineering & Construction (Industrials), while PFE operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SKBSY returned 9.11%/yr vs 1.41%/yr for PFE. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
SKBSY vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SKBSY achieves a 8.75% return, which is significantly higher than PFE's 5.63% return. Over the past 10 years, SKBSY has outperformed PFE with an annualized return of 9.11%, while PFE has yielded a comparatively lower 1.41% annualized return.
SKBSY
- 1D
- -0.32%
- 1M
- 5.15%
- 6M
- -3.60%
- YTD
- 8.75%
- 1Y
- 27.31%
- 3Y*
- 28.32%
- 5Y*
- 5.16%
- 10Y*
- 9.11%
- ALL TIME*
- 8.62%
PFE
- 1D
- 0.40%
- 1M
- 4.64%
- 6M
- -2.16%
- YTD
- 5.63%
- 1Y
- 13.94%
- 3Y*
- -5.21%
- 5Y*
- -5.31%
- 10Y*
- 1.41%
- ALL TIME*
- 9.09%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
PFE Pfizer Inc. | $911.93M | $985.34M | $1.04B |
| $523.34K | $471.19K | $448.44K |
SKBSY vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SKBSY Skanska AB ser. B ADR | 8.75% | 41.62% | 19.14% | 19.90% | -36.16% | 3.94% | 20.80% | 56.04% | -19.03% | -6.65% |
PFE Pfizer Inc. | 5.63% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between SKBSY and PFE is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jun 2, 2010 | 0.11 |
Fundamentals
SKBSY:
$11.66B
PFE:
$142.54B
SKBSY:
SEK 16.05
PFE:
$1.31
SKBSY:
16.66
PFE:
19.06
SKBSY:
0.63
PFE:
2.26
SKBSY:
1.81
PFE:
1.59
SKBSY:
SEK 175.57B
PFE:
$63.32B
SKBSY:
SEK 15.59B
PFE:
$43.91B
SKBSY:
SEK 12.28B
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SKBSY vs. PFE — Risk / Return Rank
SKBSY
PFE
SKBSY vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Skanska AB ser. B ADR (SKBSY) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SKBSY | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.32 | ||
| Sortino ratioReturn per unit of downside risk | +0.43 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.13 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | 1.48 | 0.95 | +0.53 |
| Martin ratioReturn relative to average drawdown | 3.47 | 2.13 | +1.35 |
Loading charts...
Drawdowns
SKBSY vs. PFE - Drawdown Comparison
The maximum SKBSY drawdown since its inception was -58.21%, smaller than the maximum PFE drawdown of -69.24%. Use the drawdown chart below to compare losses from any high point for SKBSY and PFE.
Loading charts...
Drawdown Indicators
| SKBSY | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.21% | -69.24% | +11.03% |
Max Drawdown (1Y)Largest decline over 1 year | -18.67% | -15.72% | -2.95% |
Max Drawdown (3Y)Largest decline over 3 years | -20.08% | -36.23% | +16.15% |
Max Drawdown (5Y)Largest decline over 5 years | -58.03% | -58.96% | +0.93% |
Max Drawdown (10Y)Largest decline over 10 years | -58.21% | -58.96% | +0.75% |
Current DrawdownCurrent decline from peak | -5.54% | -47.26% | +41.72% |
Average DrawdownAverage peak-to-trough decline | -17.05% | -22.96% | +5.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.95% | 7.03% | +0.92% |
Volatility
SKBSY vs. PFE - Volatility Comparison
Skanska AB ser. B ADR (SKBSY) has a higher volatility of 7.74% compared to Pfizer Inc. (PFE) at 5.62%. This indicates that SKBSY's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SKBSY | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.74% | 5.62% | +2.12% |
Volatility (6M)Calculated over the trailing 6-month period | 22.52% | 15.06% | +7.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.25% | 23.95% | +5.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.84% | 25.60% | +9.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.97% | 23.98% | +10.99% |
Dividends
SKBSY vs. PFE - Dividend Comparison
SKBSY's dividend yield for the trailing twelve months is around 5.32%, less than PFE's 6.88% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PFE Pfizer Inc. | 6.88% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
SKBSY Skanska AB ser. B ADR | 5.32% | 5.91% | 2.50% | 3.98% | 6.64% | 4.26% | 3.94% | 5.64% | 6.58% | 9.06% | 7.79% | 4.45% |
Financials
SKBSY vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Skanska AB ser. B ADR and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SKBSY vs. PFE - Profitability Comparison
SKBSY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Skanska AB ser. B ADR reported a gross profit of 4.57B and revenue of 48.03B. Therefore, the gross margin over that period was 9.5%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.
SKBSY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Skanska AB ser. B ADR reported an operating income of 2.37B and revenue of 48.03B, resulting in an operating margin of 4.9%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.
SKBSY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Skanska AB ser. B ADR reported a net income of 2.55B and revenue of 48.03B, resulting in a net margin of 5.3%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.
Frequently Asked Questions
SKBSY and PFE have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SKBSY has higher volatility (7.74%) compared to PFE (5.62%). In terms of maximum drawdown, SKBSY dropped -58.21% vs PFE's -69.24%.
SKBSY currently has the higher Sharpe Ratio (0.95 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SKBSY and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer